drugset / Trial / NCT04459702
A Study of Combination Therapies to Treat COVID-19 Infection
RandomizedParallel-groupDouble-blindTreatment
Summary
This study seeks to determine whether dual or quadruple therapy is more effective in treating COVID-19.
Timeline
- Start
- 2020-07
- Primary completion
- 2021-07
- Completion
- 2021-12
Outcome
Outcome not reported
Stopped: “Was never started”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lopinavir | Other / unclassified | — | — |
| Subject | Ritonavir | Other / unclassified | — | — |
| Background | Azithromycin | Small molecule | — | — |
| Background | Hydroxychloroquine | Small molecule | — | — |